| PEG-g-chitosan nanoparticles functionalized with the monoclonal antibody OX26 for brain drug targeting Y Monsalve, G Tosi, B Ruozi, D Belletti, A Vilella, M Zoli, MA Vandelli, ... Nanomedicine 10 (11), 1735-1750, 2015 | 82 | 2015 |
| Preparation and Characterization of Succinyl‐Chitosan Nanoparticles for Drug Delivery Y Monsalve, L Sierra, BL López Macromolecular Symposia 354 (1), 91-98, 2015 | 20 | 2015 |
| Study of encapsulation of polyphenols on succinyl-chitosan nanoparticles J Palacio, Y Monsalve, F Ramírez-Rodríguez, B López Journal of Drug Delivery Science and Technology 57, 101610, 2020 | 17 | 2020 |
| Role of a novel (−)-epigallocatechin-3-gallate delivery system on the prevention against oxidative stress damage in vitro and in vivo model of Parkinson's disease V Sánchez-Giraldo, Y Monsalve, J Palacio, M Mendivil-Perez, L Sierra, ... Journal of Drug Delivery Science and Technology 55, 101466, 2020 | 17 | 2020 |
| Preparation and evaluation of PLGA-PEG/Gusperimus nanoparticles as a controlled delivery anti-inflammatory drug J Palacio, Y Monsalve, JA Villa-Pulgarin, KVC Ramirez, CEN Chica, ... Journal of Drug Delivery Science and Technology 77, 103889, 2022 | 4 | 2022 |
